Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 134 Records) |
Query Trace: Leukemia and SF3B1[original query] |
---|
Clonal evolution in chronic lymphocytic leukemia is associated with an unmutated IGHV status and frequently leads to a combination of loss of TP53 and TP53 mutation. Molecular biology reports 2022 9 49 (12): 12247-12252. Bracher Susanne, Fuhrmann Irene, Jeromin Sabine, Nadarajah Niroshan, Kern Wolfgang, Haferlach Torsten, Haferlach Claudia, Stengel An |
Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia. Bone marrow transplantation 2022 Sep . Song Ga-Young, Kim TaeHyung, Ahn Seo-Yeon, Jung Sung-Hoon, Kim Mihee, Yang Deok-Hwan, Lee Je-Jung, Choi Seung Hyun, Kim Mi Yeon, Jung Chul Won, Jang Jun-Ho, Kim Hee Je, Moon Joon Ho, Sohn Sang Kyun, Won Jong-Ho, Park Seong-Kyu, Kim Sung-Hyun, Zhang Zhaolei, Ahn Jae-Sook, Kim Hyeoung-Joon, Kim Dennis Dong Hw |
SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients With Lower-Risk Myelodysplastic Syndrome. Clinical lymphoma, myeloma & leukemia 2022 Aug . Falantes Jose F, Márquez-Malaver Francisco J, Carrillo Estrella, Culebras Marta García, Morales Rosario, Prats Concepción, Vargas Maria T, Caballero Teresa, Rodríguez-Arbolí Eduardo, Espigado Ildefonso, Pérez-Simón Jose Anton |
Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations. JACC. CardioOncology 2022 Mar 4 (1): 38-49. Calvillo-Argüelles Oscar, Schoffel Alice, Capo-Chichi José-Mario, Abdel-Qadir Husam, Schuh Andre, Carrillo-Estrada Montserrat, Liu Shiying, Gupta Vikas, Schimmer Aaron D, Yee Karen, Shlush Liran I, Natarajan Pradeep, Thavendiranathan Paaladine |
Clinical and Genomic Profiles of Korean Patients with MECOM Rearrangement and the t(3;21)(q26.2;q22.1) Translocation. Annals of laboratory medicine 2022 4 42 (5): 590-596. Lee Jikyo, Kim Sung Min, Kim Soonok, Yun Jiwon, Jeong Dajeong, Lee Young Eun, Roh Eun-Youn, Lee Dong So |
Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia. Leukemia research 2022 4 116 106827. Jelloul Fatima Zahra, Yang Richard, Garces Sofia, Kanagal-Shamanna Rashmi, Ok Chi Y, Loghavi Sanam, Routbort Mark J, Zuo Zhuang, Yin C Cameron, Floyd Kristen, Bassett Roland L, Wierda William, Jain Nitin, Thompson Philip, Luthra Rajyalakshmi, Medeiros L Jeffrey, Patel Keyur |
New genetic variants of TET2 and ASXL1 identified by next generation sequencing and pyrosequencing in a patient with MDS-RS-MLD and secondary acute myeloid leukemia. Central-European journal of immunology 2022 2 46 (4): 524-530. Adamska Monika Ma?gorzata, Kowal-Wi?niewska Ewelina, Kiwerska Katarzyna, Ustaszewski Adam, Czerwi?ska-Rybak Joanna, Kandu?a Zuzanna, Wojtaszewska Marzena, Bara?ska Marta, Pruchniewski ?ukasz, Lewandowski Krzysztof, Jarmu?-Szymczak Ma?gorzata, Gil Lid |
STEREOTYPED CASES IN UKRAINIAN COHORT OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS DEPENDING ON THE IONIZING RADIATION EXPOSURE. Problemy radiatsiinoi medytsyny ta radiobiolohii 2022 12 27 307-323. Bilous N I, Abramenko I V, Chumak A A, Dyagil I S, Martina Z |
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia 2022 12 37 (2): 339-347. Mansouri Larry, Thorvaldsdottir Birna, Sutton Lesley-Ann, Karakatsoulis Georgios, Meggendorfer Manja, Parker Helen, Nadeu Ferran, Brieghel Christian, Laidou Stamatia, Moia Riccardo, Rossi Davide, Catherwood Mark, Kotaskova Jana, Delgado Julio, Rodríguez-Vicente Ana E, Benito Rocío, Rigolin Gian Matteo, Bonfiglio Silvia, Scarfo Lydia, Mattsson Mattias, Davis Zadie, Gogia Ajay, Rani Lata, Baliakas Panagiotis, Foroughi-Asl Hassan, Jylhä Cecilia, Skaftason Aron, Rapado Inmaculada, Miras Fatima, Martinez-Lopez Joaquín, de la Serna Javier, Rivas Jesús María Hernández, Thornton Patrick, Larráyoz María José, Calasanz María José, Fésüs Viktória, Mátrai Zoltán, Bödör Csaba, Smedby Karin E, Espinet Blanca, Puiggros Anna, Gupta Ritu, Bullinger Lars, Bosch Francesc, Tazón-Vega Bárbara, Baran-Marszak Fanny, Oscier David, Nguyen-Khac Florence, Zenz Thorsten, Terol Maria Jose, Cuneo Antonio, Hernández-Sánchez María, Pospisilova Sarka, Mills Ken, Gaidano Gianluca, Niemann Carsten U, Campo Elias, Strefford Jonathan C, Ghia Paolo, Stamatopoulos Kostas, Rosenquist Richa |
Prognostic correlation of NOTCH1 and SF3B1 mutations with chromosomal abnormalities in chronic lymphocytic leukemia patients. Cancer reports (Hoboken, N.J.) 2022 11 e1757. Sadria Reza, Motamed Nasrin, Saberi Anvar Mohammad, Mehrabani Yeganeh Hassan, Poopak Behz |
Impact of single versus multiple spliceosome mutations on myelodysplastic syndrome. Journal of clinical and experimental hematopathology : JCEH 2023 9 63 (3): 173-176. Pakasticali Nagehan, Mirza Sabbir, Jinming Song, Hussaini Mohamm |
Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia. Annals of hematology 2023 9 . Peter J P Croucher, Maya Ridinger, Pamela S Becker, Tara L Lin, Sandra L Silberman, Eunice S Wang, Amer M Zeid |
Copy Number Variations and Gene Mutations Identified by Multiplex Ligation-Dependent Probe Amplification in Romanian Chronic Lymphocytic Leukemia Patients. Journal of personalized medicine 2023 8 13 (8): . Beata Balla, Florin Tripon, Marcela Candea, Claudia Banes |
Clinical characterization of the mutational landscape of 24,639 real-world samples from patients with myeloid malignancies. Cancer genetics 2023 8 278-279 38-49. Grant Hogg, Eric A Severson, Li Cai, Heidi M Hoffmann, Kimberly A Holden, Kerry Fitzgerald, Angela Kenyon, Qiandong Zeng, Michael Mooney, Sabrina Gardner, Wenjie Chen, Narasimhan Nagan, Deborah Boles, Scott Parker, Tamara J Richman, Stanley Letovsky, Henry Dong, Steven M Anderson, Shakti Ramkissoon, Prasanth Reddy, Marcia Eisenberg, Anjen Chenn, Taylor J Jens |
Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis. Blood 2023 7 . P Martijn Kolijn, Florentin Späth, Mouhamad Khouja, Paul J Hengeveld, Lina Van Der Straten, Nikos Darzentas, Magnus Hultdin, James McKay, Christiane Pott, Roel C H Vermeulen, Anton W Langer |
Venetoclax Abrogates the Prognostic Impact of Splicing Factor Gene Mutations in Newly Diagnosed Acute Myeloid Leukemia. Blood 2023 7 . Jayastu Senapati, Samuel Urrutia, Sanam Loghavi, Nicholas J Short, Ghayas C Issa, Abhishek Maiti, Hussein A Abbas, Naval G Daver, Naveen Pemmaraju, Sherry A Pierce, Kelly Sharon Chien, Koji Sasaki, Tapan M Kadia, Danielle Hammond, Gautam Borthakur, Keyur P Patel, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia-Manero, Courtney D DiNar |
The clinical phenotype of germline RUNX1 mutations in relation to the accompanying somatic variants and RUNX1 isoform expression. Genes, chromosomes & cancer 2023 6 . David Cabrerizo Granados, Indira Barbosa, Panagiotis Baliakas, Eva Hellström-Lindberg, Vanessa Lund |
[Clinical features of SF3B1 mutation in patients with myelodysplastic syndrome with excess blasts]. Zhonghua nei ke za zhi 2023 6 62 (6): 681-687. F He, T Li, Y F Li, P Tang, L N Sang, Y M Huang, L Sun, L L |
Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia. Haematologica 2023 5 . Almut Lütge, Junyan Lu, Jennifer Hüllein, Tatjana Walther, Leopold Sellner, Bian Wu, Richard Rosenquist, Christopher C Oakes, Sascha Dietrich, Wolfgang Huber, Thorsten Ze |
Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease. Journal of the American College of Cardiology 2023 5 81 (20): 1996-2009. Esra D Gumuser, Art Schuermans, So Mi Jemma Cho, Zachary A Sporn, Md Mesbah Uddin, Kaavya Paruchuri, Tetsushi Nakao, Zhi Yu, Sara Haidermota, Whitney Hornsby, Lachelle D Weeks, Abhishek Niroula, Siddhartha Jaiswal, Peter Libby, Benjamin L Ebert, Alexander G Bick, Pradeep Natarajan, Michael C Honigbe |
Co-mutation of ASXL1 and SF3B1 Predicts Poorer Overall Survival Than Isolated ASXL1 or SF3B1 Mutations. In vivo (Athens, Greece) 2023 4 37 (3): 985-993. Jinming Song, Lynn Moscinski, Ethan Yang, Haipeng Shao, Mohammad Hussaini, Hailing Zha |
The clinical impact of IKZF1 mutation in acute myeloid leukemia. Experimental hematology & oncology 2023 3 12 (1): 33. Zhang Xiang, Huang Aijie, Liu Lixia, Qin Jiayue, Wang Chengcheng, Yang Min, Lou Yinjun, Wang Lei, Ni Xiong, Hu Xiaoxia, Tang Gusheng, Zhang Mengmeng, Cao Shanbo, Mao Liping, Qian Jiejin, Xu Weilai, Wei Juying, Xu Gaixiang, Meng Haitao, Mai Wenyuan, Yang Chunmei, Zhu Honghu, Tong Hongyan, Yang Jianmin, Yu Wenjuan, Wang Jianmin, Jin J |
Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations. International journal of molecular sciences 2023 2 24 (4): . Ahn Ari, Kim Hoon Seok, Kim Tong-Yoon, Lee Jong-Mi, Kang Dain, Yu Haein, Lee Chae Yeon, Kim Yonggoo, Eom Ki-Seong, Kim Myungsh |
The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasms. Leukemia research 2023 12 136 107433. Vishesh Khanna, Rong Lu, Jyoti Kumar, Alfonso Molina, Henning Stehr, Elizabeth Spiteri, Michael Spinner, Oscar Silva, Sebastian Fernandez-Pol, Brent Tan, Peter L Greenbe |
Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 11 OF1-OF8. Nitin Jain, Lisa J Croner, John N Allan, Tanya Siddiqi, Alessandra Tedeschi, Xavier C Badoux, Karl Eckert, Leo W K Cheung, Anwesha Mukherjee, James P Dean, Edith Szafer-Glusman, John F Seymo |
Genomic Mutation Profiles of Patients with Acute Myeloid Leukemia in Korea: a Single-Center Experience. Clinical laboratory 2023 11 69 (11): . Eunhee Han, Soorack Ryu, Dohyang Kim, Eun-Ha Koh, Jung-Hyun Byun, Dong-Hyun L |
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia. Leukemia 2023 10 . Jan-Niklas Eckardt, Sebastian Stasik, Christoph Röllig, Andreas Petzold, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W Krause, Regina Herbst, Mathias Hänel, Maher Hanoun, Ulrich Kaiser, Martin Kaufmann, Zdenek Rácil, Jiri Mayer, Uta Oelschlägel, Wolfgang E Berdel, Gerhard Ehninger, Hubert Serve, Carsten Müller-Tidow, Uwe Platzbecker, Claudia D Baldus, Andreas Dahl, Johannes Schetelig, Martin Bornhäuser, Jan Moritz Middeke, Christian Thie |
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 2023 1 15 (2): . Sargas Claudia, Ayala Rosa, Larráyoz María José, Chillón María Carmen, Carrillo-Cruz Estrella, Bilbao-Sieyro Cristina, Prados de la Torre Esther, Martínez-Cuadrón David, Rodríguez-Veiga Rebeca, Boluda Blanca, Gil Cristina, Bernal Teresa, Bergua Juan Miguel, Algarra Lorenzo, Tormo Mar, Martínez-Sánchez Pilar, Soria Elena, Serrano Josefina, Alonso-Domínguez Juan Manuel, García-Boyero Raimundo, Amigo María Luz, Herrera-Puente Pilar, Sayas María José, Lavilla-Rubira Esperanza, Martínez-López Joaquín, Calasanz María José, García-Sanz Ramón, Pérez-Simón José Antonio, Gómez-Casares María Teresa, Sánchez-García Joaquín, Barragán Eva, Montesinos Pau, On Behalf Of Pethema Grou |
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification. American journal of hematology 2023 1 98 (3): 398-407. Lee Wan-Hsuan, Lin Chien-Chin, Tsai Cheng-Hong, Tien Feng-Ming, Lo Min-Yen, Ni Sao-Chih, Yao Ming, Tseng Mei-Hsuan, Kuo Yuan-Yeh, Liu Ming-Chih, Tang Jih-Luh, Sun Hsun-I, Chuang Yi-Kuang, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fa |
IMMUNOPHENOTYPE OF LEUKEMIC CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH NOTCH1 AND SF3B1 GENE MUTATIONS. Experimental oncology 2024 1 45 (3): 322-327. N Golyarnik, ? ?????????, G Movchan, Z Martina, I Dyagil, A Chumak, D Bazy |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: